Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
25 juil. 2022 01h15 HE
|
Novartis Pharma AG
Submission of proposed biosimilar supported by comprehensive package; aims to expand treatment access for people with multiple sclerosis in US and EUMultiple sclerosis (MS) is a chronic inflammatory...
XCPCNL Business Services Announces Reverse Merger with Centiment Capital Holdings
22 juil. 2022 06h30 HE
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, July 22, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
Parker Seminars to Host NeuroCon 2022 Event on Parker University Campus July 29-30
18 juil. 2022 15h22 HE
|
Parker University
Dallas, Texas, July 18, 2022 (GLOBE NEWSWIRE) -- From July 29-30, 2022, join Parker Seminars for an exciting in-person, two-day event designed specifically for healthcare professionals! Attendees...
California teen receives special high school graduation while hospitalized in Arizona for paralyzing injuries from diving accident
28 juin 2022 17h17 HE
|
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
PHOENIX, June 28, 2022 (GLOBE NEWSWIRE) -- A Southern California high school student recently received his high school diploma while hospitalized in Arizona with paralyzing injuries from a diving...
NeurologyLive® Announces Giants of Multiple Sclerosis™ Inaugural Class of Inductees
03 juin 2022 09h56 HE
|
NeurologyLive®
CRANBURY, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) today announced the inaugural class of Giants of Multiple Sclerosis™...
Arvinas Launches Global Early Career Researcher Award and Announces Call for Nominations
01 juin 2022 08h00 HE
|
Arvinas Inc.
-- In honor of 20 years of targeted protein degradation, Arvinas announces $25,000 prize to recognize the efforts of an up-and-coming researcher in the field of targeted protein degradation – --...
2022 Bressler Prize Awarded to Dr. Sheila Nirenberg for Outstanding Accomplishments in Vision Science
17 mai 2022 09h12 HE
|
Lighthouse Guild
New York, May 17, 2022 (GLOBE NEWSWIRE) -- Lighthouse Guild, the leading not-for-profit vision and healthcare organization, announced today that Sheila Nirenberg, PhD, has been awarded the 2022...
neurocare group AG Announces Expansion of Clinic Network in the US
28 avr. 2022 03h00 HE
|
neurocare group AG
MUNICH, April 28, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
New Book by Psychiatrist and Mental Health Advocate Launches - The Promise of Psychedelics
22 avr. 2022 11h31 HE
|
Ingenium Books (955172)
EDMONTON, Alberta, April 22, 2022 (GLOBE NEWSWIRE) -- Easy to read, yet backed by research, Dr. Peter Silverstone's new book, The Promise of Psychedelics: Science Based Hope for Better Mental...
New Book by Psychiatrist and Mental Health Advocate, The Promise of Psychedelics, Launches Today
21 avr. 2022 10h00 HE
|
Ingenium Books
EDMONTON, Alberta, April 21, 2022 (GLOBE NEWSWIRE) -- Easy to read, yet backed by research, Dr. Peter Silverstone's new book, The Promise of Psychedelics: Science Based Hope for Better Mental...